Clinical Research Directory
Browse clinical research sites, groups, and studies.
VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome
Sponsor: Fundación EPIC
Summary
The objective of the study is to establish a de-scaling strategy of P2Y12 inhibitors (P2Y12 i) with a decrease in hemorrhagic events without increasing ischemic complications based on a Platelet Function Test (PFT).
Official title: VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA Trial)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
634
Start Date
2021-07-02
Completion Date
2026-12-04
Last Updated
2026-01-23
Healthy Volunteers
No
Conditions
Interventions
Clopidogrel
Clopidogrel during 11 months
Previous treatment
non-intervention
Locations (19)
Hospital Universitario Virgen de La Arrixaca
El Palmar, Murcia, Spain
Hospital General Universitario de Albacete
Albacete, Spain
Hospital Del Mar
Barcelona, Spain
Hospital Universitari Vall D Hebron
Barcelona, Spain
Hospital San Pedro de Alcantara
Cáceres, Spain
Hospital General Universitario de Ciudad Real
Ciudad Real, Spain
Hospital Universitario de Galdakao-Usansolo
Galdakao, Spain
Hospital Universitario de Cabueñes
Gijón, Spain
Hospital Universitario Virgen de Las Nieves
Granada, Spain
Hospital Universitario Juan Ramon Jimenez
Huelva, Spain
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Spain
Hospital de León
León, Spain
Hospital Universitario Lucus Agusti
Lugo, Spain
Hospital Universitario Regional de Malaga
Málaga, Spain
Hospital Universitario de Salamanca
Salamanca, Spain
Hospital Universitario Marques de Valdecilla
Santander, Spain
Hospital Clinico Universitario de Valladolid
Valladolid, Spain
Hospital Universitario Lozano Blesa
Zaragoza, Spain
Hospital Universitario Miguel Servet
Zaragoza, Spain